AI Analysis

Log in to generate an AI summary for this stock.

Log in to generate a MOAT report for this stock.

Log in to generate an earnings report for this stock.

Log in to generate an operating leverage report for this stock.

Log in to generate a management report for this stock.

Log in to generate a valuation report for this stock.

Aurora Spine Corporation

$0.11 -$0.09 (-44.65%)
OTC · 11 Sep 2026 20:00 UTC
Previous Close
$0.11
Day Range
$0.11$0.11
Year Range
$0.08$0.24
Market Cap
8.39M
AVG Volume
26.37K
Trailing/Forward PE
-7.02/-
PEG ratio
0.07
Dividend Yield
-
Next Earnings Date
2026-11-16
Primary Exchange
Other OTCUS
Revenue (USD)
02M4M6M24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
ASAPF Revenue (USD) by quarter
PeriodRevenue (USD)
26 Q23.57M
26 Q14.37M
25 Q45.1M
25 Q34.38M
25 Q24.5M
25 Q14.42M
24 Q44.57M
24 Q34.77M
24 Q24.08M
24 Q14M
Net Income (USD)
-1M-750K-500K-250K0250K24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
ASAPF Net Income (USD) by quarter
PeriodNet Income (USD)
26 Q2-813.57K
26 Q1-200.04K
25 Q4-41.33K
25 Q3-140.41K
25 Q2-198.76K
25 Q1-349.68K
24 Q4-634.28K
24 Q371.12K
24 Q2-154.08K
24 Q1-265.73K
Operating Income (USD)
-1M-750K-500K-250K0250K24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
ASAPF Operating Income (USD) by quarter
PeriodOperating Income (USD)
26 Q2-778.74K
26 Q1-163.5K
25 Q4149.61K
25 Q3-73.38K
25 Q2-130.46K
25 Q1-272.66K
24 Q4-441.66K
24 Q3114.47K
24 Q2-154.07K
24 Q1-221.33K
EBITDA (USD)
-1M-500K0500K1M24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
ASAPF EBITDA (USD) by quarter
PeriodEBITDA (USD)
26 Q2-525.69K
26 Q192.55K
25 Q4529.72K
25 Q3139.87K
25 Q2122.98K
25 Q1-38.83K
24 Q4-337.43K
24 Q3351.74K
24 Q298.94K
24 Q176.41K
Cash Flows (USD)
-500K-250K0250K500K24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
ASAPF Cash Flows (USD) by quarter
PeriodCash Flows (USD)
26 Q2-309.45K
26 Q1-28.2K
25 Q4448.35K
25 Q3139.69K
25 Q2146.42K
25 Q1-354.28K
24 Q4182.26K
24 Q3449.99K
24 Q2198.09K
24 Q1-335.43K
EPS (USD)
-0.01-0.01-000.0124 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
ASAPF EPS (USD) by quarter
PeriodEPS (USD)
26 Q2-0.01
26 Q1-0
25 Q4-0
25 Q3-0
25 Q2-0
25 Q1-0
24 Q4-0.01
24 Q30
24 Q2-0
24 Q1-0
Expenses (USD)
-1M01M2M3MR&DSG&ACapex24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
ASAPF Expenses (USD) by quarter
PeriodExpenses (USD)
26 Q21.39M
26 Q12.7M
25 Q42.62M
25 Q32.73M
25 Q22.7M
25 Q12.76M
24 Q42.9M
24 Q32.6M
24 Q22.6M
24 Q12.62M
Cash & Debt (USD)
01M2M3MCashLong Term DebtShort Term Debt24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
ASAPF Cash & Debt (USD) by quarter
PeriodCash & Debt (USD)
26 Q2362.2K
26 Q1780.56K
25 Q4895.08K
25 Q3665.76K
25 Q2580.98K
25 Q1488.69K
24 Q4825.13K
24 Q3882.05K
24 Q2518.47K
24 Q1366.38K
Debt ratios
-5005010024 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
ASAPF Debt ratios by quarter
PeriodDebt ratios
26 Q27.64
26 Q11.68
25 Q41.85
25 Q3-25.76
25 Q231
25 Q142.86
24 Q49.17
24 Q34.86
24 Q26.88
24 Q184.41
Margins
0%20%40%60%80%24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
ASAPF Margins by quarter
PeriodMargins
26 Q213.14%
26 Q122.18%
25 Q427.25%
25 Q325.47%
25 Q262.24%
25 Q158.02%
24 Q423.24%
24 Q360.47%
24 Q262.44%
24 Q124.12%
Return on Capital
-30%-20%-10%0%10%24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
ASAPF Return on Capital by quarter
PeriodReturn on Capital
26 Q2-28.83%
26 Q1-5.5%
25 Q4-1.09%
25 Q3-3.67%
25 Q2-5.03%
25 Q1-8.47%
24 Q4-14.43%
24 Q31.42%
24 Q2-3.13%
24 Q1-5.25%
Shares Outstanding
020M40M60M80M24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
ASAPF Shares Outstanding by quarter
PeriodShares Outstanding
26 Q278.09M
26 Q178.09M
25 Q478.09M
25 Q378.05M
25 Q277.41M
25 Q177.81M
24 Q477.59M
24 Q377.42M
24 Q277.42M
24 Q177.42M
Book Value Per Share (USD)
00.020.040.060.0824 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
ASAPF Book Value Per Share (USD) by quarter
PeriodBook Value Per Share (USD)
26 Q20.04
26 Q10.05
25 Q40.05
25 Q30.05
25 Q20.05
25 Q10.05
24 Q40.06
24 Q30.06
24 Q20.06
24 Q10.07
Total Assets (USD)
05M10M15M24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
ASAPF Total Assets (USD) by quarter
PeriodTotal Assets (USD)
26 Q28.92M
26 Q19.74M
25 Q410.39M
25 Q311.69M
25 Q211.57M
25 Q111.75M
24 Q411.67M
24 Q312.09M
24 Q211.99M
24 Q112.02M
Free Cash Flow Yield
-5%0%5%10%med 2.57%Dec 24Apr 25Jul 25Oct 25Feb 26May 26Sep 26
ASAPF Free Cash Flow Yield by quarter
PeriodFree Cash Flow Yield
Sep 268.41%
Sep 266.8%
Aug 267.46%
Aug 265.45%
Aug 266.43%
Aug 266.31%
Jul 266.3%
Jul 265.78%
Jul 265.99%
Jul 265.22%
Jul 265.4%
Jun 262.78%
Jun 263.08%
Jun 263.09%
Jun 263.27%
May 262.88%
May 262.7%
May 262.79%
May 262.7%
May 262.6%
Apr 262.37%
Apr 262.65%
Apr 262.49%
Apr 262.43%
Mar 260.8%
Mar 260.72%
Mar 260.73%
Mar 260.76%
Feb 260.7%
Feb 260.68%
Feb 260.64%
Feb 260.67%
Jan 260.64%
Jan 260.76%
Jan 260.75%
Jan 260.74%
Jan 260.75%
Dec 252.92%
Dec 252.8%
Dec 252.8%
Dec 252.92%
Nov 252.84%
Nov 252.77%
Nov 252.58%
Nov 252.56%
Oct 252.49%
Oct 252.43%
Oct 252.55%
Oct 252.57%
Oct 252.63%
Sep 252.88%
Sep 252.86%
Sep 253.09%
Sep 253.38%
Aug 253.07%
Aug 253.18%
Aug 252.91%
Aug 252.7%
Aug 252.55%
Jul 252.45%
Jul 252.52%
Jul 252.75%
Jul 252.78%
Jun 252.53%
Jun 252.9%
Jun 252.84%
Jun 252.83%
May 252.89%
May 252.83%
May 252.73%
May 252.89%
May 252.6%
Apr 252.5%
Apr 252.83%
Apr 253.36%
Apr 252.87%
Mar 25-2.89%
Mar 25-3.15%
Mar 25-3.6%
Mar 25-3.21%
Feb 25-3.16%
Feb 25-3.16%
Feb 25-2.89%
Feb 25-2.59%
Jan 25-2.37%
Jan 25-2.22%
Jan 25-2.33%
Jan 25-2.2%
Jan 25-2.49%
Dec 24-4.34%
Dec 24-4.25%
Dec 24-4.11%
Dec 24-4.27%
Nov 24-4.15%
Nov 24-3.84%
Nov 24-3.87%
Nov 24-3.86%
Nov 24-4.27%
Oct 24-3.64%
Oct 24-4.83%
Price to Sales
00.511.52med 0.92Dec 24Apr 25Jul 25Oct 25Feb 26May 26Sep 26
ASAPF Price to Sales by quarter
PeriodPrice to Sales
Sep 260.46
Sep 260.57
Aug 260.52
Aug 260.71
Aug 260.6
Aug 260.61
Jul 260.61
Jul 260.67
Jul 260.64
Jul 260.74
Jul 260.71
Jun 260.74
Jun 260.67
Jun 260.67
Jun 260.63
May 260.72
May 260.76
May 260.74
May 260.77
May 260.8
Apr 260.87
Apr 260.78
Apr 260.83
Apr 260.85
Mar 260.8
Mar 260.89
Mar 260.87
Mar 260.84
Feb 260.92
Feb 260.93
Feb 260.99
Feb 260.96
Jan 261
Jan 260.84
Jan 260.85
Jan 260.87
Jan 260.85
Dec 250.8
Dec 250.83
Dec 250.83
Dec 250.8
Nov 250.82
Nov 250.84
Nov 250.9
Nov 250.91
Oct 250.94
Oct 250.96
Oct 250.91
Oct 250.9
Oct 250.89
Sep 250.93
Sep 250.93
Sep 250.87
Sep 250.79
Aug 250.87
Aug 250.84
Aug 250.92
Aug 250.99
Aug 251.05
Jul 251.09
Jul 251.06
Jul 250.97
Jul 250.96
Jun 251.12
Jun 250.98
Jun 251
Jun 251
May 250.98
May 251
May 251.04
May 250.98
May 251.09
Apr 251.14
Apr 251
Apr 250.85
Apr 250.99
Mar 251.14
Mar 251.04
Mar 250.92
Mar 251.03
Feb 251.04
Feb 251.04
Feb 251.14
Feb 251.27
Jan 251.39
Jan 251.49
Jan 251.41
Jan 251.5
Jan 251.32
Dec 241.36
Dec 241.39
Dec 241.44
Dec 241.39
Nov 241.42
Nov 241.54
Nov 241.53
Nov 241.53
Nov 241.39
Oct 241.63
Oct 241.22
EV/EBITDA
0200400600800med 88.22Sep 24Jan 25Apr 25Aug 25Nov 25May 26Sep 26
ASAPF EV/EBITDA by quarter
PeriodEV/EBITDA
Sep 2611.16
Sep 2613.42
Aug 2612.37
Aug 2616.32
Aug 2614.09
Aug 2614.33
Jul 2614.35
Jul 2615.48
Jul 2615
Jul 2616.96
Jul 2616.45
Jun 2619.98
Jun 2618.22
Jun 2618.18
Jun 2617.28
May 2619.39
May 2620.5
May 2619.9
May 2620.55
May 2621.25
Apr 2623.09
Apr 2620.9
Apr 2622.12
Apr 2622.57
Dec 25178.42
Dec 25184.95
Dec 25184.78
Dec 25178.81
Nov 25182.59
Nov 25186.52
Nov 25198.39
Nov 25199.57
Oct 25204.44
Oct 25208.69
Oct 25200.15
Oct 25198.47
Oct 25195.17
Sep 25265.07
Sep 25266.89
Sep 25250.21
Sep 25232.12
Aug 25251.14
Aug 25244.15
Aug 25262.45
Aug 25280.23
Aug 25294.13
Jul 25304.28
Jul 25297.17
Jul 25275.62
Jul 25272.91
Jun 25112.27
Jun 2599.18
Jun 25100.92
Jun 25101.26
May 2599.35
May 25101.22
May 25104.86
May 2599.55
May 25109.41
Apr 25113.46
Apr 25101.22
Apr 2586.9
Apr 25100
Mar 2538.21
Mar 2535.46
Mar 2531.68
Mar 2534.89
Feb 2535.45
Feb 2535.4
Feb 2538.23
Feb 2542.08
Jan 2545.55
Jan 2548.38
Jan 2546.23
Jan 2548.77
Jan 2543.6
Dec 2476.19
Dec 2477.74
Dec 2480
Dec 2477.4
Nov 2479.3
Nov 2485.18
Nov 2484.7
Nov 2484.84
Nov 2477.41
Oct 2489.54
Oct 2469.13
Oct 2459.16
Oct 2458.12
Sep 24695.96
Sep 24639.08
Sep 24630.54
Sep 24594.13
Aug 24639.08
Aug 24648.03
Aug 24710.19
Aug 24671.5
Aug 24645.33
Jul 24707.34
Jul 24653.3
Price/Operating Cashflow
050100150200250med 21.17Jun 21Apr 25Jul 25Oct 25Feb 26May 26Sep 26
ASAPF Price/Operating Cashflow by quarter
PeriodPrice/Operating Cashflow
Sep 267.8
Sep 269.66
Aug 268.8
Aug 2612.05
Aug 2610.21
Aug 2610.41
Jul 2610.42
Jul 2611.36
Jul 2610.96
Jul 2612.57
Jul 2612.16
Jun 2614.75
Jun 2613.32
Jun 2613.29
Jun 2612.56
May 2614.27
May 2615.17
May 2614.69
May 2615.22
May 2615.79
Apr 2617.28
Apr 2615.5
Apr 2616.5
Apr 2616.86
Mar 2626.37
Mar 2629.46
Mar 2628.9
Mar 2627.87
Feb 2630.3
Feb 2630.9
Feb 2632.89
Feb 2631.65
Jan 2633.24
Jan 2627.69
Jan 2628.02
Jan 2628.66
Jan 2628.07
Dec 2520.17
Dec 2521.06
Dec 2521.04
Dec 2520.22
Nov 2520.74
Nov 2521.28
Nov 2522.9
Nov 2523.06
Oct 2523.73
Oct 2524.31
Oct 2523.14
Oct 2522.91
Oct 2522.46
Sep 2519.11
Sep 2519.27
Sep 2517.83
Sep 2516.28
Aug 2517.91
Aug 2517.31
Aug 2518.88
Aug 2520.41
Aug 2521.61
Jul 2522.48
Jul 2521.87
Jul 2520.02
Jul 2519.78
Jun 2521.65
Jun 2518.9
Jun 2519.27
Jun 2519.34
May 2518.94
May 2519.33
May 2520.1
May 2518.98
May 2521.05
Apr 2521.9
Apr 2519.33
Apr 2516.33
Apr 2519.08
Sep 21154.97
Sep 21191.8
Sep 21193.07
Sep 21203.85
Aug 21196.24
Aug 21193.93
Aug 21194.72
Aug 21192.29
Jul 21206.38
Jul 21191.15
Jul 21185.03
Jul 21193.63
Jul 21195.71
Jun 2199.44
Jun 21104.31
Jun 21111.29
Jun 21103.09
May 21100.96
May 21115.62
May 21110.97
May 21101.12
Apr 21110.01
Apr 21111.33
Apr 21112.79
Price to Book
23456med 3.97Dec 24Apr 25Jul 25Oct 25Feb 26May 26Sep 26
ASAPF Price to Book by quarter
PeriodPrice to Book
Sep 262.31
Sep 262.86
Aug 262.6
Aug 263.57
Aug 263.02
Aug 263.08
Jul 263.09
Jul 263.36
Jul 263.24
Jul 263.72
Jul 263.6
Jun 263.59
Jun 263.24
Jun 263.24
Jun 263.06
May 263.47
May 263.69
May 263.58
May 263.7
May 263.84
Apr 264.21
Apr 263.77
Apr 264.02
Apr 264.1
Mar 263.72
Mar 264.15
Mar 264.08
Mar 263.93
Feb 264.27
Feb 264.36
Feb 264.64
Feb 264.46
Jan 264.69
Jan 263.9
Jan 263.95
Jan 264.04
Jan 263.96
Dec 253.68
Dec 253.84
Dec 253.83
Dec 253.69
Nov 253.78
Nov 253.88
Nov 254.17
Nov 254.2
Oct 254.32
Oct 254.43
Oct 254.22
Oct 254.18
Oct 254.09
Sep 254.01
Sep 254.04
Sep 253.74
Sep 253.41
Aug 253.75
Aug 253.63
Aug 253.96
Aug 254.28
Aug 254.53
Jul 254.71
Jul 254.58
Jul 254.2
Jul 254.15
Jun 254.45
Jun 253.88
Jun 253.96
Jun 253.97
May 253.89
May 253.97
May 254.13
May 253.9
May 254.33
Apr 254.5
Apr 253.97
Apr 253.35
Apr 253.92
Mar 253.85
Mar 253.54
Mar 253.1
Mar 253.47
Feb 253.53
Feb 253.53
Feb 253.85
Feb 254.3
Jan 254.7
Jan 255.03
Jan 254.78
Jan 255.07
Jan 254.48
Dec 244.48
Dec 244.58
Dec 244.73
Dec 244.56
Nov 244.68
Nov 245.06
Nov 245.03
Nov 245.04
Nov 244.56
Oct 245.35
Oct 244.03
Aurora Spine Corporation
ASAPF
Stockpicker

Video analysis: ASAPF

All videos

No video analysis for this stock yet. Request one from our team.

Your email is used only to follow up on this request. We do not add you to marketing lists. Privacy Policy

News: ASAPF

Aurora Spine Corporation Announces Second Quarter FY26 Financial Results

newsfilecorp.com · 27 Aug 2026

Aurora Spine Corporation Announces Second Quarter FY26 Financial Results

- Company to host conference call Today, August 27th at 11am ET/8am PT - NOT FOR DISTRIBUTION IN THE UNITED STATES OR OVER UNITED STATES WIRE SERVICES Carlsbad, California--(Newsfile Corp. - August 27, 2026) - Aurora Spine Corporation (TSXV: ASG) (OTCQB: ASAPF) ("Aurora Spine" or the "Company"), a leader in the development of groundbreaking medical devices for spinal surgery, today announced its financial results for the second quarter of fiscal year 2026 ended June 30, 2026. All figures are in U.S. dollars.

Aurora Spine Announces Settlement of Arbitration, New Patent License Agreement for SI Joint Product and Increase in Funding from Insider

newsfilecorp.com · 14 Aug 2026

Aurora Spine Announces Settlement of Arbitration, New Patent License Agreement for SI Joint Product and Increase in Funding from Insider

Carlsbad, California--(Newsfile Corp. - August 14, 2026) - Aurora Spine Corporation (TSXV: ASG) ("Aurora Spine" or the "Company") announced today that it has entered into a new non-exclusive license to US patent #9,451,986 titled "Percutaneous sacroiliac joint implant and method for surgically inserting and securing the implant into the sacroiliac joint" in an agreement with SILIF Corporation of New York, New York ("SILIF"). The new patent license replaces a previous version that the Company utilized in developing its market leading SiLO TFX Transfixing SI Joint System.

Aurora Spine and CornerLoc Announce Strategic Commercial Alliance to Expand Minimally Invasive Spine and SI Joint Solutions Nationwide

newsfilecorp.com · 16 Jul 2026

Aurora Spine and CornerLoc Announce Strategic Commercial Alliance to Expand Minimally Invasive Spine and SI Joint Solutions Nationwide

Carlsbad, California and Tulsa, Oklahoma--(Newsfile Corp. - July 16, 2026) - Aurora Spine Corporation ("Aurora Spine" or the "Company") (TSXV: ASG) (OTCQB: ASAPF), a leader in the development of groundbreaking medical devices for spinal surgery and Foundation Fusion Solutions, LLC dba CornerLoc, founded on one idea: provide patients with an intelligent and lasting solution for SI joint fusion, today announced the formation of a Strategic Commercial Alliance designed to expand physician access to innovative minimally invasive spine and sacroiliac (SI) joint technologies across the United States. The alliance brings together Aurora Spine's comprehensive portfolio of minimally invasive spine technologies, public company infrastructure, manufacturing capabilities, engineering expertise, and regulatory resources with CornerLoc's specialized SI joint fusion technologies, reimbursement expertise, physician education programs, and strong relationships within the interventional pain community.

Similar companies

Disclaimer: The historical data presented on this platform is provided by Financial Modeling Prep. Stock Picker is a platform for informational purposes only and does not provide financial advice. Users are encouraged to conduct their own research and consult with a qualified financial advisor before making investment decisions.